Literature DB >> 7883442

Antibody responses of sheep to challenge with Trichostrongylus colubriformis and the effect of dexamethasone treatment.

P G Douch1, R S Green, P L Risdon.   

Abstract

Eight-month-old random bred Romney wether lambs were reared nematode-free in pens and assigned to 4 groups each of 5 lambs. Lambs in 3 groups were infected orally, twice a week, with 5000 Trichostrongylus colubriformis infective larvae (L3), a control group remained unifected throughout. Two infected groups were treated with dexamethasone (0.5 mg kg-1 bodyweight), one between days -7 and 77, the other between days 77-154. Nematode challenge infection was withheld from the third group from day 133 after anthelmintic treatment. Nematode eggs in sheep faeces (FEC) were monitored at weekly intervals. T. colubriformis-specific antibody levels were determined twice a week and specific immunoglobulin isotypes (IgA, IgG1, IgG2 and IgM) determined weekly in serum samples using ELISA. Resistance, as measured by FEC, was expressed by 35 days after L3 infection began but sheep dosed with dexamethasone did not develop resistance. Extant resistance was abrogated in sheep dosed with dexamethasone. Nematode challenge resulted in elevated serum levels of antibodies to T. colubriformis L3 excretory/secretory antigens, these consisted predominantly of IgG1 and IgM. The IgG1 response was more persistent than the IgM response. Specific serum IgA and IgG2 responses were low, but significant, in nematode-challenge sheep. Dexamethasone treatment prevented the antibody responses and resulted in a rapid reduction of extant antibody levels in resistant sheep. Weight gain was reduced by nematode challenge with or without dexamethasone treatment compared with control sheep.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7883442     DOI: 10.1016/0020-7519(94)90155-4

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  7 in total

1.  Increased expression of interleukin-5 (IL-5), IL-13, and tumor necrosis factor alpha genes in intestinal lymph cells of sheep selected for enhanced resistance to nematodes during infection with Trichostrongylus colubriformis.

Authors:  Anton Pernthaner; Sally-Ann Cole; Lilian Morrison; Wayne R Hein
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  The effect of anthelmintic capsules on the egg output and larval viability of drug-resistant parasites.

Authors:  I A Sutherland; A E Brown; D M Leathwick
Journal:  Vet Res Commun       Date:  2003-02       Impact factor: 2.459

3.  The effect of continuous drug exposure on the immune response of lambs challenged with drug-susceptible or drug-resistant nematode larvae.

Authors:  I A Sutherland; D M Leathwick; R S Green; C M Miller; A E Brown
Journal:  Vet Res Commun       Date:  1998-07       Impact factor: 2.459

4.  Discovery of quantitative trait loci for resistance to parasitic nematode infection in sheep: I. Analysis of outcross pedigrees.

Authors:  Allan M Crawford; Korena A Paterson; Ken G Dodds; Cristina Diez Tascon; Penny A Williamson; Meredith Roberts Thomson; Stewart A Bisset; Anne E Beattie; Gordon J Greer; Richard S Green; Roger Wheeler; Richard J Shaw; Kevin Knowler; John C McEwan
Journal:  BMC Genomics       Date:  2006-07-18       Impact factor: 3.969

Review 5.  The host immune response to gastrointestinal nematode infection in sheep.

Authors:  K M McRae; M J Stear; B Good; O M Keane
Journal:  Parasite Immunol       Date:  2015-12       Impact factor: 2.280

6.  Immunoglobulins as Biomarkers for Gastrointestinal Nematodes Resistance in Small Ruminants: A systematic review.

Authors:  H M Aboshady; M J Stear; A Johansson; E Jonas; J C Bambou
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

Review 7.  Effect of gastro-intestinal nematode infection on sheep performance: a systematic review and meta-analysis.

Authors:  Fabien Mavrot; Hubertus Hertzberg; Paul Torgerson
Journal:  Parasit Vectors       Date:  2015-10-24       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.